Senior insider sale
Chief Executive Officer at TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$11.33M
344.09K shares
What this filing means
DUBE ERIC M plans to sell 344.09K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $11.33M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/15/2026ACC: 0001959173-26-002926
DirectorOfficer· Chief Executive Officer
Since Jan 2019
344.09K
Shares to sell
$11.33M
Approx. market value
64K
Acquired (3 months)
1
Planned
5 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
4/13/2026
64KTotal acquired64K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/13/2026 | Restricted Stock Vesting Compensation | 64K | — |
| Total | 64K | ||
Planned & Completed Dispositions6
Completed
—Completed
Units to sell
60K
Market value
$1.86M
4/1/2026
—Completed
Units to sell
60K
Market value
$1.81M
2/20/2026
—Completed
Units to sell
100.09K
Market value
$3.23M
2/3/2026
—Completed
Units to sell
51.87K
Market value
$1.56M
1/27/2026
—Completed
Units to sell
8.13K
Market value
$244.2K
1/23/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
64K
Market value
$2.63M
4/15/2026
Total
Units
344.09K
Value
$11.33M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/1/2026 | 60K | $1.86M | — | Completed |
2/20/2026 | 60K | $1.81M | — | Completed |
2/3/2026 | 100.09K | $3.23M | — | Completed |
1/27/2026 | 51.87K | $1.56M | — | Completed |
1/23/2026 | 8.13K | $244.2K | — | Completed |
| Planned — Approximate Date | ||||
4/15/2026 | 64K | $2.63M | NASDAQ | Planned |
| Total | 344.09K | $11.33M | ||